Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing
Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22